CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Julianne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback